NDC 50222-346-02
Adbry 150 mg/mL
tralokinumab-ldrm · INJECTION, SOLUTION
Adbry is a injection, solution containing tralokinumab-ldrm at a strength of 150 mg/mL. Manufactured by LEO Pharma Inc..
Key Facts
- Brand Name
- Adbry
- Generic Name
- tralokinumab-ldrm
- NDC Code (Package)
50222-346-02- NDC Code (Product)
50222-346- Manufacturer
- LEO Pharma Inc.
- Strength
- 150 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761180
- Drug Class
- Interleukin-13 Antagonist [EPC]
- Marketing Start
- 01/02/2022
Recall History
No Recall HistoryView Full Drug Page
Adbry — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.